Section Arrow
Quote
SCLX.NASDAQ
- Scilex Holding Company
Quotes are at least 15-min delayed:2026/03/10 04:41 EDT
Pre Market
Last
 --
-- (--)
Bid
7.68
Ask
9
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 8.58
+0.18 (+2.14%)
Day High 
8.615 
Prev. Close
8.4 
1-M High
9.5033 
Volume 
16.86K 
Bid
7.68
Ask
9
Day Low
8.0001 
Open
8.31 
1-M Low
7.68 
Market Cap 
59.08M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 8.33 
20-SMA 8.34 
50-SMA 10.19 
52-W High 34.27 
52-W Low 3.6 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-40.46/6.53
Enterprise Value
61.45M
Balance Sheet
Book Value Per Share
-25.16
Cash Flow
Cash Flow Yield
0.33
Income Statement
Total Revenue
56.59M
Operating Revenue Per Share
6.61
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MDCXMedicus Pharma Ltd0.52+0.1348+34.99%-- 
Pre Market 0.6093 +0.0994 +19.49%
PFEPfizer26.81-0.24-0.89%19.84PE
Pre Market 26.91 +0.1 +0.37%
NVONovo-Nordisk A/S39.78+1.2+3.11%10.75PE
Pre Market 39.51 -0.27 -0.68%
BMYBristol-Myers Squibb Co60.63+0.34+0.56%17.41PE
Pre Market 60.43 -0.2 -0.33%
MRKMerck & Co117.11+1.32+1.14%15.9PE
Pre Market 117.14 +0.03 +0.03%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.